Abstract
In this study, the activity of 15-LOX-1 was first evaluated in two prostate cancer cell lines PC3 and DU145. Considering the enzyme inhibitory potency of 5-farnesyloxycoumarin (5f), the cytotoxic effects of this compound was studied in PC3, DU145 and HFF3 (normal cell line) by MTT assay. Since 5f was more effective on PC3 cells, this cell line was used for further explorations. The chromatin condensation and DNA damage were studied by DAPI staining and comet assay, respectively and cell cycle analysis was performed by propidium iodide staining. Results indicated that 15-LOX-1 activity was very low in DU145 cells. Moreover, PC3 cells were more sensitive to 5f as compared to DU145 cancerous cells, while no significant effect was observed on normal HFF3 cells. Interestingly, the IC50 values of 5f on PC3 cells were similar to cisplatin. DAPI staining showed that 5f induced chromatin condensation in 63 % of PC3 cells. Comet assay also demonstrated 53 % “DNA in tail” for PC3 cells. Finally, 5f induced G0/G1 arrest in PC3 cell cycle. These findings suggest that cytotoxic effects of 5f might be due to the inhibition of 15-LOX-1 in PC3 cell line and, it can be introduced as a potent anticancer compound.
Similar content being viewed by others
References
Barthomeuf C, Lim S, Iranshahi M, Chollet P (2008) Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu metastatic pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis. Phytomedicine 15:103–111
Bilgin HM, Atmaca M, Obay BD, Özekinci S, Taşdemir E, Ketani A (2011) Protective effects of coumarin and coumarin derivatives against carbon tetrachloride-induced acute hepatotoxicity in rats. Exp Toxicol Pathol 63:325–330
Borges F, Roleira F, Milhazes N, Santana L, Uriarte E (2005) Simple coumarins and analogues in medicinal chemistry: occurrence, synthesis and biological activity. Curr Med Chem 12:887–916
Borges MFM, Roleira FMF, Villares EU, Penin LS (2008) Simple coumarins: privileged scaffolds in medicinal chemistry. Fron Med Chem 4:23–85
Brash AR, Boeglin WE, Chang MS (1997) Discovery of a second 15S-lipoxygenase in humans. Proc Natl Acad Sci USA 94:6148–6152
Burke JE, Dennis EA (2009) Phospholipase A2 biochemistry. Cardiovasc Drugs Ther 23:49–59
Comba A, Pasqualini ME (2009) Primers on molecular pathways lipoxygenases: their role as an oncogenic pathway in pancreatic cancer. Pancreatology 9:724–728
Daurkin I, Eruslanov E, Stoffs T, Perrin GQ, Algood C, Gilbert SM et al. (2011) Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway. Cancer Res 71:6400–6409
Eleftheriadis N, Thee S, Biesebeek J, Wouden P, Baas BJ, Dekker FJ (2015) Identification of 6-benzyloxysalicylates as a novel class of inhibitors of 15-lipoxygenase-1. Eur J Med Chem 94:265–275
Goel A, Prasad AK, Parmar VS, Ghosh B, Saini N (2009) Apoptogenic effect of 7,8-diacetoxy-4-methylcoumarin and 7,8-diacetoxy-4-methylthiocoumarin in human lung adenocarcinoma cell line: role of NF-kappaB, Akt, ROS and MAP kinase pathway. Chem Biol Interact 179:363–374
Gulappa T, Reddy RS, Suman S, Nyakeriga AM, Damodaran C (2013) Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells. Cancer Lett 337:177–183
Haghighi F, Matin MM, Bahrami AR, Iranshahi M, Rassouli FB, Haghighitalab A (2014) The cytotoxic activities of 7-isopentenyloxycoumarin on 5637 cells via induction of apoptosis and cell cycle arrest in G2/M stage. DARU 22:1–10
Hyde CAC, Missailidis S (2009) Inhibition of arachidonic acid metabolism and its implication on cell proliferation and tumor-angiogenesis. Int Immunopharmacol 9:701–715
Ilic D, Neuberger MM, Djulbegovic M, Dahm P (2013) Screening for prostate cancer. Cochrane Database Syst Rev 1:CD004720
Iranshahi M, Askari M, Sahebkar A, Hadjipavlou-Litina D (2009) Evaluation of antioxidant, anti-inflammatory and lipoxygenase inhibitory activities of the prenylated coumarin umbelliprenin. DARU 17:99–103
Iranshahi M, Jabbari A, Orafaie A, Mehri R, Zeraatkar S, Ahmadi T et al. (2012) Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors. Eur J Med Chem 57:134–142
Kelavkar UP, Parwani AV, Shappell SB, Martin WD (2006) Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model. Neoplasia 8:510–522
Kelavkar UP, Glasgow W, Olson SJ, Foster BA, Shappell SB (2004) Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice. Neoplasia 6:821–830
Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, Badr KF (2001) Overexpression of 15-lipoxygenase-1 in PC3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 22:1765–1773
Lee SH, Park C, Jin CY, Kim GY, Moon SK, Hyun JW, Lee WH et al. (2008) Involvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human leukemia U937 cells. Biomed Pharmacother 62:723–729
Meng Z, Cao R, Yang Z, Liu T, Wang YZ, Wang X (2013) Inhibitor of 5-Lipoxygenase, Zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and Paxillin. Urology 82:1452.e7–1452.e14
Murakami A, Nishizawa T, Egawa K, Kawada T, Nishikawa Y, Uenakai K et al. (2005) New class of linoleic acid metabolites biosynthesized by corn and rice lipoxygenases: suppression of pro-inflammatory mediator expression via attenuation of MAPK and Akt, but not PPARγ dependent pathways in stimulated macrophages. Biochem Pharmacol 70:1330–1342
Napagoda M, Gerstmeier J, Wesely S, Popella S, Lorenz S, Scheubert K et al. (2014) Inhibition of 5-lipoxygenase as anti-inflammatory mode of action of Plectranthus zeylanicus Benth and chemical characterization of ingredients by a mass spectrometric approach. J Ethnopharmacol 151:800–809
Rassouli FB, Matin MM, Iranshahi M, Bahrami AR, Behravan J, Mollazadeh S et al. (2011) Investigating the enhancement of cisplatin cytotoxicity on 5637 cells by combination with mogoltacin. Toxicol In Vitro 25:469–474
Ribeiro D, Freitas M, Tomé SM, Silva AMS, Porto G, Cabrita EJ et al. (2014) Inhibition of LOX by flavonoids: a structure–activity relationship study. Eur J Med Chem 72:137–145
Riveiro ME, Moglioni A, Vazquez R, Gomez N, Facorro G, Piehl L et al. (2008) Structural insights into hydroxycoumarin-induced apoptosis in U-937 cells. Bioorg Med Chem 16:2665–2675
Sadeghian H, Seyedi SM, Saberi MR, Arghiani Z, Riazi M (2008) Design and synthesis of eugenol derivatives, as potent 15-lipoxygenase inhibitors. Bioorg Med Chem 16:890–901
Sadeghian H, Attaran N, Jafari Z, Saberi MR, Pordel M, Riazi MM (2009) Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of them. Bioorg Med Chem 17:2327–2335
Schneider C, Pozzi A (2011) Cyclooxygenases and lipoxygenases in cancer. Cancer Metastasis Rev 30:277–294
Shappell SB, Gupta RA, Manning S, Whitehead R, Boeglin WE, Schneider C et al. (2001) 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res 61:497–503
Spindler SA, Sarkar FH, Sakr WA, Blackburn ML, Bull AW, La Gattuta M, Reddy RG (1997) Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines. Biochem Biophys Res Commun 239:775–781
Tehrani MB, Emami S, Asadi M, Saeedi M, Mirzahekmati M, Ebrahimi SM et al. (2014) Imidazo [2,1-b] thiazole derivatives as new inhibitors of 15-lipoxygenase. Eur J Med Chem 87:759–764
Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181–193
Wang CJ, Hsieh YJ, Chu CY, Lin YL, Tseng TH (2002) Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett 183:163–168
Yamamoto S, Suzuki H, Nakamura M, Ishimura K (1999) Arachidonate 12-lipoxygenase isozymes. Adv Exp Med Biol 447:37–44
Acknowledgments
This work was supported by a grant from Ferdowsi University of Mashhad. The authors would like to thank Dr. Behnam—Rassouli, Mr. Malaekeh—Nikouei and Mr. Nakhaei for their excellent support and technical help.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Orafaie, A., Sadeghian, H., Bahrami, A.R. et al. 5-farnesyloxycoumarin: a potent 15-LOX-1 inhibitor, prevents prostate cancer cell growth. Med Chem Res 26, 227–234 (2017). https://doi.org/10.1007/s00044-016-1737-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-016-1737-1